Uropathogenic escherichia coli induces serum amyloid a in mice following urinary tract and systemic inoculation

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Erman, Andreja ^a   Lakota, Katja ^b   Mrak Poljsak, Katjusa ^b   Blango, Matthew G ^c   Krizan Hergouth, Veronika ^a   Mulvey, Matthew A ^c   Sodin Semrl, Snezna ^b   Veranic, Peter ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM AMYLOID A; SERUM AMYLOID A1 PROTEIN; SERUM AMYLOID A2 PROTEIN; SERUM AMYLOID A3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BIOFILM; BLADDER CATHETERIZATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; HOST RESISTANCE; IN VITRO STUDY; INOCULATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYSTEMIC DISEASE; UPREGULATION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; UROTHELIUM; ANIMAL; C57BL MOUSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

ANIMALS; BIOFILMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION; SERUM AMYLOID A PROTEIN; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84858054144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032933     Document Type: Article

References (37)

1. Blango MG, Mulvey MA, (2010) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54: 1855-1863.
2. Eto DS, Sundsbak JL, Mulvey MA, (2006) Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol 8: 704-717.
3. Cai Z, Cai L, Jiang J, Chang KS, van der Westhuyzen DR, et al. (2007) Human serum amyloid A protein inhibits hepatitis C virus entry into cells. J Virol 81: 6128-6133.
4. Hari-Dass R, Shah C, Meyer DJ, Raynes JG, (2005) Serum amyloid A protein binds to outer membrane protein A of gram-negative bacteria. J Biol Chem 280: 18562-18567.
5. Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MK, et al. (2010) Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog 6: e1000893.
6. Lavie M, Voisset C, Vu-Dac N, Zurawski V, Duverlie G, et al. (2006) Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system. Hepatology 44: 1626-1634.
7. Misse D, Yssel H, Trabattoni D, Oblet C, Lo Caputo S, et al. (2007) IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol 178: 407-415.
8. Renckens R, Roelofs JJ, Knapp S, de Vos AF, Florquin S, et al. (2006) The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii Pneumonia. J Infect Dis 193: 187-195.
9. Shah C, Hari-Dass R, Raynes JG, (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108: 1751-1757.
10. Hirakura Y, Carreras I, Sipe JD, Kagan BL, (2002) Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense. Amyloid 9: 13-23.
11. Wang L, Lashuel HA, Walz T, Colon W, (2002) Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proc Natl Acad Sci U S A 99: 15947-15952.
12. Eckhardt ER, Witta J, Zhong J, Arsenescu R, Arsenescu V, et al. (2010) Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis. BMC Gastroenterol 10: 133.
13. Nicholson TF, Watts KM, Hunstad DA, (2009) OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect Immun 77: 5245-5251.
14. Prasadarao NV, Wass CA, Weiser JN, Stins MF, Huang SH, et al. (1996) Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun 64: 146-153.
15. Smith SG, Mahon V, Lambert MA, Fagan RP, (2007) A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol Lett 273: 1-11.
16. Wu HH, Yang YY, Hsieh WS, Lee CH, Leu SJ, et al. (2009) OmpA is the critical component for Escherichia coli invasion-induced astrocyte activation. J Neuropathol Exp Neurol 68: 677-690.
17. Jorgensen JB, Lunde H, Jensen L, Whitehead AS, Robertsen B, (2000) Serum amyloid A transcription in Atlantic salmon (Salmo salar L.) hepatocytes is enhanced by stimulation with macrophage factors, recombinant human IL-1 beta, IL-6 and TNF alpha or bacterial lipopolysaccharide. Dev Comp Immunol 24: 553-563.
18. Lin B, Chen S, Cao Z, Lin Y, Mo D, et al. (2007) Acute phase response in zebrafish upon Aeromonas salmonicida and Staphylococcus aureus infection: striking similarities and obvious differences with mammals. Mol Immunol 44: 295-301.
19. Meijer AH, Verbeek FJ, Salas-Vidal E, Corredor-Adamez M, Bussman J, et al. (2005) Transcriptome profiling of adult zebrafish at the late stage of chronic tuberculosis due to Mycobacterium marinum infection. Mol Immunol 42: 1185-1203.
20. Ordas A, Hegedus Z, Henkel CV, Stockhammer OW, Butler D, et al. (2011) Deep sequencing of the innate immune transcriptomic response of zebrafish embryos to Salmonella infection. Fish Shellfish Immunol 31: 716-724.
21. Wu Z, Zhang W, Lu Y, Lu C, (2010) Transcriptome profiling of zebrafish infected with Streptococcus suis. Microb Pathog 48: 178-187.
22. Orro T, Sankari S, Pudas T, Oksanen A, Soveri T, (2004) Acute phase response in reindeer after challenge with Escherichia coli endotoxin. Comp Immunol Microbiol Infect Dis 27: 413-422.
23. Lakota K, Thallinger GG, Cucnik S, Bozic B, Mrak-Poljsak K, et al. (2011) Could antibodies against serum amyloid A function as physiological regulators in humans? Autoimmunity 44: 149-158.
24. Notebaert S, Demon D, Vanden Berghe T, Vandenabeele P, Meyer E, (2008) Inflammatory mediators in Escherichia coli-induced mastitis in mice. Comp Immunol Microbiol Infect Dis 31: 551-565.
25. Reigstad CS, Lunden GO, Felin J, Backhed F, (2009) Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS One 4: e5842.
26. Uhlar CM, Whitehead AS, (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265: 501-523.
27. Gunther J, Koczan D, Yang W, Nurnberg G, Repsilber D, et al. (2009) Assessment of the immune capacity of mammary epithelial cells: comparison with mammary tissue after challenge with Escherichia coli. Vet Res 40: 31.
28. Gardiner GE, O'Flaherty S, Casey PG, Weber A, McDonald TL, et al. (2009) Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease. FEMS Immunol Med Microbiol 55: 404-413.
29. Lloyd AL, Rasko DA, Mobley HL, (2007) Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189: 3532-3546.
30. Mulvey MA, Schilling JD, Hultgren SJ, (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69: 4572-4579.
31. Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, et al. (1997) The complete genome sequence of Escherichia coli K-12. Science 277: 1453-1462.
32. Kulesus RR, Diaz-Perez K, Slechta ES, Eto DS, Mulvey MA, (2008) Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. Infect Immun 76: 3019-3026.
33. Casl MT, Sabljar-Matovinovic M, Kovacevic S, Pocanic D, Preden-Kerekovic V, et al. (1993) Clinical relevance of serum amyloid A protein monitoring in urinary tract infections. Ann Clin Biochem 30 (Pt 3): 272-277.
34. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M, (1993) Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 39: 293-297.
35. Badolato R, Wang JM, Stornello SL, Ponzi AN, Duse M, et al. (2000) Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J Leukoc Biol 67: 381-386.
36. Bower JM, Gordon-Raagas HB, Mulvey MA, (2009) Conditioning of uropathogenic Escherichia coli for enhanced colonization of host. Infect Immun 77: 2104-2112.
37. Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, et al. (2006) Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect 12: 1034-1036.